What Superbrewed Food makes
Superbrewed Food is a fermentation company that builds ingredients from whole bacterial cells. Its website describes a platform it calls Whole-Cell Intelligence, in which proteins, nutrients, bioactives and functional components of a cell work together. The company formerly traded as White Dog Labs Its stated goal is to create ingredients that deliver more across nutrition, health and formulation.
Two ingredients carry the business. Thryvia is a protein-derived postbiotic for digestive and immune health, and SB1 is a postbiotic cultured protein described as a new category of protein nutrition. Both are described as natural, non-GMO and science-backed. Readers can compare this approach with single-cell protein from other microbes and with fermented plant protein.
The company states that its discovery work draws on more than ten billion naturally evolved microorganisms and that development from concept to a pilot-ready microbe averages under three months. It also reports 37 issued and 67 pending patents. These figures describe pipeline capacity, not tonnes sold, so treat them as indicators of research intensity.
SB1 and Thryvia
SB1 is described as delivering high-quality nutrition and muscle protein synthesis comparable to dairy proteins, in an easy-to-formulate ingredient from fermentation. It carries the GRAS label and is in commercial development with select partners, now open to additional customers. The timeline cites a clinical study at Nutrition 2026 in which SB1 matched whey in muscle-building response.
The same timeline lists several partnership steps: a strategic investment from Döhler Ventures after SB1 reached commercial production, a collaboration with Fonterra on next-generation protein nutrition, and work with Bel on a new generation of cheese products. It adds a United States patent for the protein. Each of these is a headline, and contract terms and volumes remain commercial matters.
Thryvia is made from heat-killed, non-viable Clostridium tyrobutyricum strain ASM#19. The company says it is not a live probiotic, so its activity does not depend on viability. It is shelf-stable, needs no cold chain, suits UHT-processed beverages and a broad pH range, and is backed by a safety package covering toxicology, genotoxicity, allergenicity, exposure modelling and human tolerability.
Regulatory status and claims
The homepage reports the world’s first FDA no-questions letter for a bacteria biomass protein, with broad food and beverage uses established as GRAS. Thryvia is also listed with GRAS documentation. A GRAS conclusion applies to the United States, and the pages say nothing on European novel food applications, so buyers elsewhere should ask about status first.
Functional claims deserve care. The muscle synthesis comparison with whey rests on a human clinical presentation, and the Thryvia benefit statements concern immune and digestive support. In many markets these are health claims governed by authorised lists. A formulator should request the full studies, doses, populations and endpoints, and have legal review of any claim.
The company offers evidence and data on request and links to GRAS documentation. This helps due diligence, because a technical team can check the notified intended uses, the ingredient specification and the safety data against the planned application. Allergen and microbiological specifications should also be requested for each grade supplied.
What a buyer would check
Start with availability. Thryvia is described as commercially available, whereas SB1 is in development with select partners, so the practical route for SB1 is a development agreement. Ask about volumes, lead times, minimum orders and the production site, and whether a co-development contract gives exclusivity in a category such as sports nutrition, dairy analogues or cheese.
Next, consider formulation behaviour. A bacterial protein biomass will differ from whey or pea in solubility, taste, colour and heat stability, so statements about easy formulation have to be tested in real products. Pilot batches should compare sensory scores, texture and shelf life, and check how nucleic acid content is handled in declarations.
Finally, look at positioning and labelling. The terms postbiotic and cultured protein are marketing categories, and regulators may expect other names on ingredient lists. Ask the supplier for approved descriptors in each target market, plus statements on animal-free status and non-GMO verification. An audit and a second-source plan suit a product moving from pilot to scale.